IMC Logo.jpg
US DoD Uniformed Services University Travelers’ Diarrhea Clinical Update
November 15, 2021 06:00 ET | Immuron Limited
Key Points Manufacture of investigational medical products to support the Uniformed Services University (USU) clinical program to evaluate the efficacy of Travelan® and two other non-antibiotic OTC...
IMC Logo.jpg
US DoD Naval Medical Research Center Clinical Update
November 10, 2021 06:00 ET | Immuron Limited
Key Points Manufacture of investigational medical products to support the US Naval Medical Research Centre (NMRC) clinical programs completed.IND submission to the U.S. Food and Drug administration...
IMC Logo.jpg
IMM-124E – Demonstrates Antiviral T-Cell Immunity
October 08, 2021 06:00 ET | Immuron Limited
Key Points International Patent Filed Publication from the Hebrew University - Hadassah Medical Center Entitled: Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical...
IMC Logo.jpg
Immuron Director resignation
September 23, 2021 23:00 ET | Immuron Limited
MELBOURNE, Australia, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
IMC Logo.jpg
Immuron planned Acquisition of R&D Vaccine Company
September 23, 2021 09:00 ET | Immuron Limited
MELBOURNE, Australia, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
Innovation Metals Corp. Successfully Completes Initial Extraction-Rate Testing of the RapidSX™ Technology for Rare-Earth Elements Separation
July 06, 2021 09:50 ET | Innovation Metals Corp.
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce the successful completion of initial extraction-rate testing of its proprietary...
IMC Logo.jpg
IMM124E – May offer a New modality for Inhibition of SARS-CoV-2
May 13, 2021 06:00 ET | Immuron Limited
Key Points Monash University Research Update on SARS-CoV-2 programBiomedicine Discovery Institute initiates program to isolate and identify the inhibitory molecule/s in IMM-124E Appointment of Chief...
innovationMetals-logo-2020-06-01-final.png
Innovation Metals Corp. Announces Execution of RapidSX™ Separation Technology Testing Agreement with Rare-Earth Producer
May 04, 2021 10:04 ET | Innovation Metals Corp.
TORONTO, May 04, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to announce the execution of a binding Technology Testing Agreement (“TTA”) with a leading,...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
April 08, 2021 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Innovation Metals Corp. Provides Market Commentary on Recent Rare-Earth Industry Developments
February 22, 2021 11:06 ET | Innovation Metals Corp.
TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Innovation Metals Corp. (“IMC” or the “Company”) is pleased to provide the following commentary on recent notable developments in the rare-earth elements...